Literature DB >> 33308183

Maximum chest CT score is associated with progression to severe illness in patients with COVID-19: a retrospective study from Wuhan, China.

Jianwei Xiao1, Xiang Li1, Yuanliang Xie1, Zengfa Huang1, Yi Ding1, Shengchao Zhao1, Pei Yang1, Dan Du1, Bin Liu1, Xiang Wang2.   

Abstract

BACKGROUND: The Coronavirus Disease 2019 (COVID-19) pandemic is a world-wide health crisis. Limited information is available regarding which patients will experience more severe disease symptoms. We evaluated hospitalized patients who were initially diagnosed with moderate COVID-19 for clinical parameters and radiological feature that showed an association with progression to severe/critical symptoms.
METHODS: This study, a retrospective single-center study at the Central Hospital of Wuhan, enrolled 243 patients with confirmed COVID-19 pneumonia. Forty of these patients progressed from moderate to severe/critical symptoms during follow up. Demographic, clinical, laboratory, and radiological data were extracted from electronic medical records and compared between moderate- and severe/critical-type symptoms. Univariable and multivariable logistic regressions were used to identify the risk factors associated with symptom progression.
RESULTS: Patients with severe/critical symptoms were older (p < 0.001) and more often male (p = 0.046). A combination of chronic obstructive pulmonary disease (COPD) and high maximum chest computed tomography (CT) score was associated with disease progression. Maximum CT score (> 11) had the greatest predictive value for disease progression. The area under the receiver operating characteristic curve was 0.861 (95% confidence interval: 0.811-0.902).
CONCLUSIONS: Maximum CT score and COPD were associated with patient deterioration. Maximum CT score (> 11) was associated with severe illness.

Entities:  

Keywords:  COPD; COVID-19; CT score; Chest CT; Multivariate regression; ROC

Year:  2020        PMID: 33308183     DOI: 10.1186/s12879-020-05683-3

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  4 in total

Review 1.  Serum hydroxybutyrate dehydrogenase and COVID-19 severity and mortality: a systematic review and meta-analysis with meta-regression.

Authors:  Angelo Zinellu; Panagiotis Paliogiannis; Ciriaco Carru; Arduino A Mangoni
Journal:  Clin Exp Med       Date:  2021-11-19       Impact factor: 5.057

2.  A retrospective study of association of CT severity with clinical profile and outcomes of patients with COVID-19 in the second wave.

Authors:  Neema Agarwal; Payal Jain; Tooba Naved Khan; Aakash Raja
Journal:  J Clin Imaging Sci       Date:  2022-04-26

3.  A novel reliability-based regression model to analyze and forecast the severity of COVID-19 patients.

Authors:  Negar Bakhtiarvand; Mehdi Khashei; Mehdi Mahnam; Somayeh Hajiahmadi
Journal:  BMC Med Inform Decis Mak       Date:  2022-05-05       Impact factor: 3.298

4.  Comparison of Different Slice Thicknesses on Chest Computed Tomography for Evaluation of COVID-19- Associated Pneumonia.

Authors:  Dilara Atasoy; Nazım Çetinkaya; Halil Çaylak; Rağıp Sarıismailoğlu; Mehmet Haydar Atalar
Journal:  Turk Thorac J       Date:  2022-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.